Feed OASMY
OA

Vivesto AB OASMY OTC · Healthcare · Sweden

$0.00 +0.00% +$0.00

Summary

39 / 100 · Bulios Score

What speaks for it

  • It could repay all its net debt from 0.0 years of operating profit.

What to watch

  • It passes only 1 of the 9 points of the Piotroski financial health test.
  • For every 100 SEK of bills due within a year it has 38 SEK of short-term assets.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks cheap
Valuation in detail

Is it growing?

It is shrinking

Revenue (SEK)

  • Analyst estimate

There is not enough revenue history yet to say how fast it grows.

Growth in detail

Does it make money?

Income figures for the last 12 months are not available.

Profitability in detail

Is it financially healthy?

Its debt is larger than its cash.

Financial health in detail

Does it pay a dividend?

High, at risk
Yield
676.00%

You receive $0.00 per share a year. The payout is more than the company can comfortably cover.

Dividends in detail

What do analysts expect?

No coverage

No analyst covers this stock.

Analysts in detail

What does it earn on?

By product

This revenue breakdown is on the way.

By region

This revenue breakdown is on the way.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy